Furthermore, it is generally known that des-gamma-carboxy prothrombin (DCP) is an abnormal form of the coagulation protein and is considered a complementary biomarker to alpha fetoprotein (AFP) for assessing the risk of developing HCC. This evidence concerns the gene ACE and hepatocellular carcinoma.